KRAS and malignant colon neoplasm: Kirsten rat sarcoma viral oncogene (KRAS) is located downstream of EGFR signals, and KRAS mutations lead to its constitutive activation (6), which makes advanced colon cancer less responsive to anti-EGFR monoclonal antibodies such as cetuximab and panitumumab (7, 8).